MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

Catherine M Shachaf1, Andrew M Kopelman, Constadina Arvanitis

  • 1Division of Medical Oncology, Department of Medicine, Stanford University, California 94305, USA.

Nature
|October 12, 2004
PubMed

Insights

Inactivating the MYC oncogene causes invasive liver cancers to regress by differentiating tumor cells into normal liver cells. Reactivating MYC restores cancer, revealing a dormant state in hepatocellular carcinoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Hepatocellular carcinoma (HCC) presents significant clinical treatment challenges due to its refractory nature.
  • The MYC oncogene plays a critical role in the development and progression of various cancers, including HCC.

Purpose of the Study:

  • To investigate the therapeutic potential of MYC oncogene inactivation in treating invasive liver cancers.
  • To elucidate the cellular and molecular mechanisms underlying tumor regression and dormancy following MYC inactivation.

Main Methods:

  • Inactivation of the MYC oncogene in a liver cancer model.
  • In vivo bioluminescence imaging to monitor tumor cell behavior.
  • Analysis of cell differentiation markers (alpha-fetoprotein, cytokeratin 8, carcinoembryonic antigen, cytokeratin 19).
  • Array comparative genomic hybridization (aCGH) to assess genomic stability and clonal origin.

Main Results:

  • MYC inactivation induced sustained regression of invasive liver cancers.
  • Tumor cells differentiated into hepatocytes and biliary cells, forming bile duct structures.
  • Differentiation was marked by altered expression of specific tumor and liver cell markers.
  • MYC-inactivated cells entered a dormant state, retaining their neoplastic potential.
  • MYC reactivation immediately restored neoplastic features, with cells being clonally derived from original tumor cells.

Conclusions:

  • Inactivation of the MYC oncogene is a viable strategy for inducing regression in hepatocellular carcinoma.
  • Oncogene inactivation can reverse tumorigenesis by promoting tumor cell differentiation and dormancy.
  • This approach highlights the potential to exploit the pluripotent capacity of tumor cells for cancer therapy, even in difficult-to-treat cancers.

Related Concept Videos

Logarithmic Differentiation01:28

Logarithmic Differentiation

When a car’s weight and driving forces act on a tire, they impose an external load on the rubber material. This load is resisted internally by forces distributed throughout the tire structure, which are defined as stress. The resulting deformation of the rubber due to this stress is quantified as strain. The relationship between stress and strain governs how the tire deforms under load and is central to understanding its mechanical response during operation.Rubber exhibits a nonlinear...
75
Implicit Differentiation01:25

Implicit Differentiation

In classical mechanics, motion is often described through relationships between spatial coordinates and time. A car moving along a straight highway with constant acceleration serves as a simple case where velocity is an explicit function of time. This scenario results in a linear equation, enabling straightforward analysis using basic differentiation techniques.In contrast, a satellite in circular orbit follows a path defined by an implicit function. The position of the satellite is constrained...
69
X-Inactivation01:58

X-Inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
42.7K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.7K
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.7K